Executive functions are impaired in patients with Parkinson's disease with visual hallucinations

Journal of Neurology, Neurosurgery, and Psychiatry
J Barnes, L Boubert

Abstract

Although cognitive impairment has been identified as a risk factor for visual hallucinations (VHs), more specific neuropsychological deficits underlying such phenomena have not been established. Here, we investigate the link between executive dysfunction and the occurrence of VHs. We evaluated three groups--17 patients with Parkinson's disease (PD) with VHs, 20 patients with PD without VHs and 20 age-matched controls--on a battery of tests previously reported to evaluate executive functions, namely tests of inhibitory ability, short-term memory and working memory. Differences were found on tests of inhibitory ability, for which the patient group with VHs showed impairment when compared with the non-hallucinating group. Patients with PD with VHs have substantially greater impairment of inhibitory ability than patients without VHs. These findings support interactive models of the genesis of visual hallucinations in PD.

Citations

May 22, 2010·Molecular Psychiatry·A Fasano, I Petrovic
Sep 17, 2009·Brain : a Journal of Neurology·Anne Marthe MeppelinkTeus van Laar
Jan 28, 2014·Current Treatment Options in Neurology·Jennifer G Goldman, Samantha Holden
Jul 25, 2013·Future Neurology·Daniel Collerton, John-Paul Taylor
Feb 15, 2014·Progress in Neurobiology·James M ShineSimon J G Lewis
Jul 10, 2010·The International Journal of Neuroscience·Jim BarnesKsenija Maravic
Sep 7, 2013·Journal of Neuropsychology·Georg Dirnberger, Marjan Jahanshahi
Apr 19, 2015·Brain : a Journal of Neurology·James GratwickeThomas Foltynie
Mar 20, 2015·Cognitive Neuropsychiatry·Mohamad El HajStéphane Raffard
May 3, 2011·Consciousness and Cognition·Daniel Collerton, Elaine Perry
Jul 15, 2016·Brain : a Journal of Neurology·Rimona S WeilHuw R Morris
Jan 21, 2017·Nature Reviews. Neurology·Dominic H FfytcheDag Aarsland
Jan 7, 2017·Parkinsonism & Related Disorders·Abhishek LenkaPramod Kumar Pal
Aug 2, 2015·Journal of Geriatric Psychiatry and Neurology·Sarah StraughanVicki Bruce
Oct 3, 2017·Psychological Medicine·A SchmidtS Borgwardt
Feb 23, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Cristina Sanchez-CastanedaCarme Junque
Nov 1, 2010·Wiley Interdisciplinary Reviews. Cognitive Science·Daniel Collerton, Urs Peter Mosimann
Mar 26, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Kolbjorn BronnickDag Aarsland
Oct 6, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Aleksandra KudlickaJohn V Hindle
Aug 5, 2010·International Journal of Geriatric Psychiatry·G GrahamD Collerton
Oct 21, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Gisela LlebariaJaime Kulisevsky
Sep 5, 2012·Journal of Clinical and Experimental Neuropsychology·Julie H KeraiE Charles Leek
Apr 24, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Dag AarslandDaniel Weintraub
Aug 2, 2017·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S A FactorF C Goldstein
Mar 16, 2015·Movement Disorders Clinical Practice·James M ShineSimon J G Lewis
Sep 27, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Javier PagonabarragaJaime Kulisevsky
Sep 8, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Alison YarnallDavid J Burn
Sep 29, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·James M ShineSimon J G Lewis
Aug 19, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Anne Marthe MeppelinkTeus van Laar
Jan 24, 2020·Movement Disorders Clinical Practice·Sonali DaveDominic H Ffytche
Jun 13, 2017·Cognitive Research: Principles and Implications·Alan Robert BowmanDaniel Collerton
Jan 11, 2020·Frontiers in Pharmacology·Mirella RussoMarco Onofrj
Nov 19, 2020·The Journal of Neuropsychiatry and Clinical Neurosciences·Ian H KratterLuke C Henry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Blanca Ramírez-RuizEduardo Tolosa
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Feriha OzerRaziye Tiras
Nature Reviews. Neurology
Nico J DiederichC G Goetz
Dementia and Geriatric Cognitive Disorders
Blanca Ramírez-RuizEduardo Tolosa
© 2021 Meta ULC. All rights reserved